| Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld's syndrome). | |
| | |
MedLine Citation:
|
PMID: 22235042 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Objective: To investigate the clinical, laboratory and histological manifestations of patients who received illegal injections of foreign substances for cosmetic purposes. Patients and methods: We studied patients who met the following inclusion criteria: 1) history of application of foreign substances for cosmetic purposes, 2) clinical data of autoimmune disease or non-specific autoimmune manifestation (i.e. arthralgias, myalgia, malaise, fever, and weight loss), 3) detection of autoantibodies in patients' sera, 4) histological evidence of chronic inflammation and/or granulomatous reaction to foreign body. Results: Fifty female patients aged 44.4 ± 10 years were studied. The mean time between application of foreign substances and onset of symptoms was 4.5 ± 4.3 years. Patients were followed for 12 ± 7.5 years. Forty-one patients were injected with mineral oil, nine patients received other substances: three iodine gadital, one guayacol, one guayacol plus silicone fluid, two collagen, two silicone fluid. The sites of application were: buttocks (36), legs and/or thighs (11), breasts (eight) hands and face (one), face (two) (seven patients received an injection to more than one site). Thirty patients presented with non-specific autoimmune manifestations, whereas 20 patients fulfilled the criteria for a defined autoimmune disease such as systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, overlap syndrome, autoimmune hemolytic anemia, autoimmune thyroiditis, autoimmune hepatitis, and ulcerative colitis. Conclusions: Cases of human adjuvant disease following illegal injections of oil substances for cosmetic purposes are reported. Patients presented with defined autoimmune diseases as well as with non-specific autoimmune manifestations. Illegal injection of these substances could lead to serious local and systemic complications, even to death. These cases represent another model of Autoimmune/inflammatory Syndrome Induced by Adjuvants (ASIA). The use of these substances should be prohibited. |
| | |
Authors:
|
O Vera-Lastra; G Medina; M Del Pilar Cruz-Dominguez; P Ramirez; Ja Gayosso-Rivera; H Anduaga-Dominguez; C Lievana-Torres; Lj Jara |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Lupus Volume: 21 ISSN: 1477-0962 ISO Abbreviation: Lupus Publication Date: 2012 |
Date Detail:
|
Created Date: 2012-01-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9204265 Medline TA: Lupus Country: England |
Other Details:
|
Languages: eng Pagination: 128-35 Citation Subset: IM |
Affiliation:
|
1Hospital de Especialidades Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Mexico City, México; |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Silicone and scleroderma revisited.
Next Document: Autoimmune Syndrome Induced by Adjuvants (ASIA) in the Middle East: morphea following silicone impla...